Nephrology Medical News about microalbuminuria

Your Unread Messages

See All

Tracy Hampton, PhD

FDA Update

Pazopanib Approved for Advanced Kidney Cancer

Roberta Buell, MBA
Congress Proposes SGR Fix

Dorothy J. Schirf, MD

Technology Advances

Radiosurgery Trial Sparks Optimism for Early Lung Cancer

Sara Hartley

Cancer Science

Using Embryonic Stem Cells to Test Breast Cancer Genes

See All Messages (38 new messages)

Hello, Suzanne Dixon
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment

5. Debunking Myths in the US Healthcare System

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Role of altered insulin signaling pathways in the pathogenesis of podocyte malfunction and microalbuminuria
Current Opinion in Nephrology and Hypertension, 10/16/09

Jauregui A et al. – Understanding the role of podocytes in glucose metabolism is important because it may lead to the discovery of novel pathogenetic mechanisms of diabetic nephropathy, it may affect current strategies for prevention and treatment of diabetic nephropathy, and it may allow the identification of novel therapeutic targets.

<< Previous
Lymphocyte markers and prediction of long-term renal allograft...

Next >>
Advanced kidney disease, gadolinium and nephrogenic systemic...